TSX-V Symbol "ERG"
MONTREAL, July 25 /CNW Telbec/ - Ergoresearch Ltd. ("Ergoresearch") is
pleased to announce the deployment of a new promotion strategy aimed at
increasing retail sales of its foot orthotics. In collaboration with
participating pharmacies from the two main banners in Quebec, Ergoresearch has
deployed a new approach that should increase business at its various service
points, while benefiting its pharmacist partners.
Ergoresearch conducted market tests throughout the spring, creating
cooperative advertising focused on its 3-D foot orthotics along with chosen
pharmacies. All preliminary findings were positive. This project is part of a
broader strategy aimed at refocusing marketing efforts on the selling of foot
orthotics.
According to Ergoresearch's new CEO, Mr. Sylvain Boucher, O.D., "the
selling of foot orthotics in Quebec has become a competitive market where
innovation is key to success; Ergoresearch certainly gains a comparative
advantage from its Expert-Fit(TM) technology used in the conception of high
quality custom-made orthotics that specifically tailor the needs of each
customer."
Close to four months after acquiring and integrating Clinique du Pied
Equilibre Inc. into its own sales network, Ergoresearch's CEO indicated that
new selling efforts proved to be very encouraging.
Ergoresearch Ltd. is a leading Canadian manufacturer of custom-made foot
orthotics and a state-of-the-art designer of durable medical equipment for
this sector of the orthopaedics market. The company aims at becoming an
international leader in the development of technologies and solutions directed
at the improvement of foot health.
This document contains prospective statements based on current
expectations, forecasts and assumptions. These statements involve risk and
uncertainty factors that could influence actual results. These factors
include, among other things: market fluctuations, competition, availability of
specialized labour, and technological developments.
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
%SEDAR: 00016933EF
Ergoresearch further develops its retail business
Later from Ergoresearch
- For the first time of its history, Ergoresearch is reaching profitibality
- TSX Venture Exchange - Trading Halt - Ergoresearch Ltd. - ERG
- TSX Venture Exchange - Trade Resumption - Ergoresearch Ltd. - ERG
- Ergoresearch is announcing the most profitable second quarter of its history
- Ergoresearch grants stock options
Follow Ergoresearch into a list and get an email when it puts out news.
Follow Ergoresearch